Coexistent multiple myeloma or increased bone marrow plasma cells define equally high-risk populations in patients with immunoglobulin light chain amyloidosis

Journal of Clinical Oncology

Volumn 31, Issue 34, 2013, Pages 4319-4324

  Kourelis, Taxiarchis V ^a   Kumar, Shaji K ^a   Gertz, Morie A ^a   Lacy, Martha Q ^a   Buadi, Francis K ^a   Hayman, Suzanne R ^a   Zeldenrust, Steven ^a   Leung, Nelson ^a   Kyle, Robert A ^a   Russell, Stephen ^a   Dingli, David ^a   Lust, John A ^a   Lin, Yi ^a   Kapoor, Prashant ^a   Rajkumar, S Vincent ^a   McCurdy, Arleigh ^a   Dispenzieri, Angela ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN LIGHT CHAIN; BIOLOGICAL MARKER;

ADULT; AGE; AGED; AMYLOIDOSIS; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW CELL; BONE MARROW PLASMA CELL; CALCIUM RENAL ANEMIA AND BONE LESION CRITERIA; CANCER MORTALITY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN LIGHT CHAIN AMYLOIDOSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; OVERALL SURVIVAL; PLASMA CELL; PRIORITY JOURNAL; BLOOD; BONE MARROW; BONE MARROW EXAMINATION; CHI SQUARE DISTRIBUTION; COMPLICATION; IMMUNOLOGY; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK FACTOR; TIME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AMYLOIDOSIS; BIOLOGICAL MARKERS; BONE MARROW; BONE MARROW EXAMINATION; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIPLE MYELOMA; MULTIVARIATE ANALYSIS; PLASMA CELLS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; TIME FACTORS;

EID: 84892882204     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.50.8499     Document Type: Article

References (21)

1. Desikan KR, Dhodapkar MV, Hough A, et al: Incidence and impact of light chain associated (AL) amyloidosis on the prognosis of patients with multiple myeloma treated with autologous transplantation. Leuk Lymphoma 27:315-319, 1997 (Pubitemid 27501190)
2. Siragusa S, Morice W, Gertz MA, et al: Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma: A series of 144 cases and a review of the literature. Ann Hematol 90:101-106, 2011
3. International Myeloma Working Group: Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: A report of the International Myeloma Working Group. Br J Haematol 121:749-757, 2003
4. Goodman HJ, Wechalekar AD, Hawkins PN: Amyloidosis, not myeloma. Br J Haematol 129:158- 159, 2005
5. Kyle RA, Gertz MA: Primary systemic amyloidosis: Clinical and laboratory features in 474 cases. Semin Hematol 32:45-59, 1995 (Pubitemid 24370135)
6. Kumar S, Dispenzieri A, Lacy MQ, et al: Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements. J Clin Oncol 30:989-995, 2012
7. Paiva B, Vídriales MB, Pérez JJ, et al: The clinical utility and prognostic value of multiparameter flow cytometry immunophenotyping in light-chain amyloidosis. Blood 117:3613-3616, 2011
8. Dispenzieri A, Gertz MA, Kyle RA, et al: Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: A staging system for primary systemic amyloidosis. J Clin Oncol 22:3751-3757, 2004 (Pubitemid 41095215)
9. Gertz MA, Comenzo R, Falk RH, et al: Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am J Hematol 79:319-328, 2005 (Pubitemid 41098849)
10. Rajkumar SV, Fonseca R, Dispenzieri A, et al: Methods for estimation of bone marrow plasma cell involvement in myeloma: Predictive value for response and survival in patients undergoing autologous stem cell transplantation. Am J Hematol 68: 269-275, 2001 (Pubitemid 33108430)
11. Leung N, Rajkumar SV: Renal manifestations of plasma cell disorders. Am J Kidney Dis 50:155- 165, 2007 (Pubitemid 46962862)
12. Cordes S, Dispenzieri A, Lacy MQ, et al: Ten-year survival after autologous stem cell transplantation for immunoglobulin light chain amyloidosis. Cancer 118:6105-6109, 2012
13. Kyle RA, Bayrd ED: "Primary" systemic amyloidosis and myeloma: Discussion of relationship and review of 81 cases. Arch Intern Med 107:344- 353, 1961
14. Dinner S, Witteles W, Witteles R, et al: The prognostic value of diagnosing concurrent multiple myeloma in immunoglobulin light chain amyloidosis. Br J Haematol 161:367-372, 2013
15. Kyle RA, Greipp PR, O'Fallon WM: Primary systemic amyloidosis: Multivariate analysis for prognostic factors in 168 cases. Blood 68:220-224, 1986 (Pubitemid 16033633)
16. Madan S, Dispenzieri A, Lacy MQ, et al: Clinical features and treatment response of light chain (AL) amyloidosis diagnosed in patients with previous diagnosis of multiple myeloma. Mayo Clin Proc 85:232-238, 2010
17. Vela-Ojeda J, García-Ruiz Esparza MA, Padilla-González Y, et al: Multiple myeloma-associated amyloidosis is an independent high-risk prognostic factor. Ann Hematol 88:59-66, 2009
18. Rajkumar SV, Gertz MA, Kyle RA: Primary systemic amyloidosis with delayed progression to multiple myeloma. Cancer 82:1501-1505, 1998 (Pubitemid 28164996)
19. Gertz MA, Kyle RA, Greipp PR: The plasma cell labeling index: A valuable tool in primary systemic amyloidosis. Blood 74:1108-1111, 1989 (Pubitemid 19210031)
20. Dispenzieri A, Gertz MA, Buadi F: What do I need to know about immunoglobulin light chain (AL) amyloidosis? Blood Rev 26:137-154, 2012
21. Kumar SK, Gertz MA, Lacy MQ, et al: Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk score. Mayo Clin Proc 86:12-18, 2011